- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04017000
Bladder Shaper Test (BlaST)
BLAdder Shape Test: Medium-fill Cystometry and Trans-abdominal Assessment of Bladder Shape in Women With Overactive Bladder
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study hypothesises that bladder shape changes associated with involuntary contractions of the detrusor muscle, might be detected using trans abdominal ultrasound, which could itself form the basis of a novel diagnostic test for detecting involuntary contractions associated with overactive bladder syndrome and urgency incontinence.
The detection of involuntary bladder contractions currently relies on invasive internal pressure measurement, commonly termed Urodynamics. This is an invasive test involving the placement of pressure measurement catheters, usually via the urethra into the bladder and via the anal canal into the rectum. In its normal healthy state, the bladder remains a contractile throughout filling and is compliant, meaning that there is minimal or zero increase in pressure as it fills. During Urodynamics, the bladder is filled artificially, using a pump, with water or contrast medium via a urethral catheter, whilst abdominal pressure is measured via a rectal catheter introduced anally. Differences between pressure measurements in the bladder and the abdomen are used to detect involuntary detrusor contractions; termed 'detrusor over activity when detected during Urodynamics. Patients often report Urodynamics as being uncomfortable and undignified, and the test carries a risk of introducing urinary tract infection. Furthermore, there are significant issues relating to the sensitivity of Urodynamics in the detection of abnormal bladder contractions in the context of Overactive Bladder.
Variations in bladder shape have been observed in association with detrusor over activity during video-Urodynamics, when fluoroscopic images are captured during filling with contrast medium. At one extreme, women with neuropathic overactive bladder have been observed to have tense, spherical or dome-shaped bladders with trabeculations 'fir tree' or 'Christmas tree' bladder. In women with normal detrusor muscle function, the bladder outline appears relaxed and a contractile, following the contours of the pelvis when assessed by cystography.
Although conventional Urodynamics has previously been regarded as the 'Gold Standard' in the assessment of lower urinary tract disorders, it is also well recognised as having issues of sensitivity, patient acceptability and cost. The test is commonly employed to diagnose and better understand the underlying pathophysiology of incontinence and is often deemed necessary, particularly prior to invasive forms of treatment. The requirement for urodynamic equipment, including its purchase, maintenance, associated training and size restricts its use to specialist hospital facilities, rendering it relatively inaccessible as a diagnostic tool. In addition to this patients have reported finding Urodynamics embarrassing and uncomfortable and with the inclusion of x-ray screening (video-cystometry) which is part of the procedure which aims to contemporaneously evaluate lower urinary tract structure and morphology, involves exposure to ionising radiation and is of unproven benefit. Therefore, there is a patient & clinical need to objectively assess lower urinary tract function with less invasive, sensitive, reproducible and more widely available tests.
A pilot study will now be performed to establish the use of bladder shape testing as a new investigation for the assessment and diagnosis of lower urinary tract disorders. It is anticipated that this pilot will lead to the development of a new healthcare product that can be used in the primary care setting as an alternative to urodynamic assessment in the acute secondary care environment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Sheffield, United Kingdom
- Sheffield Teaching Hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women referred for urodynamic evaluation of LUTS, including urinary storage symptoms, with or without incontinence.
- Women aged 18 years and over.
- Women willing and able to discontinue any current anticholinergic medication for a minimum period of 10 days prior to starting any study-related procedure.
- Women who understand and are willing and feel able to comply with the study protocol/procedures and who have provided written informed consent.
Exclusion Criteria:
- Current pregnancy
- Suspicion of pelvic malignancy
- Unable to consume 1000ml still water over 20 minutes
- Current urinary tract infection (UTI) (as assessed by urine dipstick and symptomatology. Patients with current UTI will be treated and further BlaST/Urodynamics appointments offered as appropriate. Women with cyclical urinary symptoms in association with menstrual cycle will be scheduled for BlaST and conventional Urodynamics at the same time each month, other patients will receive both tests usually within a month of each other, but never on the same day.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: BlaST study
Patients scheduled for Urodynamic clinic will be offered to participate in the study. Once consented to participate, the participant will be scheduled for a bladder shape test clinic at least one week in advance of their Urodynamic appointment. At their blast clinic, participants will attend a clinical room with a portable bladder scanner. Participants will be asked to consume up to 1000 mls of water over a 20-30 period until their bladder is full. The participant will have their bladder scanned at 10 minute intervals during the filling phase and after prompted voiding. The participants Urodynamic clinic will run according to routine care. |
Capturing images of bladder under natural filling conditions images are analysed at a later date for shape change.
|
OTHER: Calibration Sub Study
Any patients who are not eligible or decline participation in the main study will be offered the chance to participate in the calibration sub study. Participants will be scheduled for their clinically indicated Urodynamic appointment where they will have their bladder imaged by portable ultrasound. Participants will consent for these images to be used as part of the calibration of the technology being used to measure bladder shape change. |
Capturing images of bladder under artificial filling conditions during Urodynamic assessment images are analysed at a later date to inform shape change technology.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recruitment
Time Frame: At 12 months
|
Assessing recruitment rate for a larger study
|
At 12 months
|
Participants Completion Rate
Time Frame: At 12 months
|
Assessing drop out and completing patients to inform sample size for larger study
|
At 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Stephen Radley, Sheffield Teaching Hospitals NHS Foundation Trust
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STH20318
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diagnosis of Urinary Tract Symptons
-
Heinrich HussleinMedical-Scientific Fund of the Mayor of the Federal Capital ViennaRecruitingEndometriosis (Diagnosis) | Identification of Biomarkers in SerumAustria
-
University Hospital, Basel, SwitzerlandCompletedUrinary Tract Infection (Diagnosis)Switzerland
-
Mayo ClinicRecruitingExtramammary Paget Disease | Paget Disease, Extramammary | Extramammary Paget's Disease | Extramammary Paget's Disease of Vulva (Diagnosis) | Extramammary Paget's Disease of Vagina (Diagnosis) | Extramammary Paget's Disease Vulva Invasive | Extramammary Paget's Disease of Anus (Diagnosis) | Extramammary... and other conditionsUnited States
-
Second Affiliated Hospital, School of Medicine,...CompletedNonunion of Fracture of Tibia (Diagnosis)China
-
ClearNote HealthRecruitingDiagnosis of Cancer of Various OrgansUnited States
-
University of Milano BicoccaCompletedDisorder of Muscle of Pelvic Region and Thigh (Diagnosis)Italy
-
Hera Biotech, Inc.RecruitingEndometriosis | DiagnosisUnited States
-
University of AlbertaRecruitingValidation Study of Molecular Diagnostic System | Development of Reporting System for Molecular Diagnosis | Incorporate Molecular Diagnosis Into Diagnostic StandardsUnited States, Switzerland, Austria, Croatia, Slovenia, Canada, Czechia, France, Germany, Ireland, Korea, Republic of, Poland, Spain, United Kingdom
-
Fox Chase Cancer CenterJohnson & Johnson; Mauna Kea TechnologiesActive, not recruitingDiagnosis of Peripheral Lung NodulesUnited States, Netherlands
-
Koç UniversityNot yet recruitingLower Urinary Tract Symptoms | Diagnosis
Clinical Trials on Bladder Shape Test
-
London Health Sciences CentrePacific Edge LimitedUnknown
-
Asan Medical CenterNational Cancer Center, Korea; Samsung Medical Center; Pusan National University... and other collaboratorsRecruitingBladder Cancer | Hematuria; BenignKorea, Republic of
-
East and North Hertfordshire NHS TrustKDx Diagnostics Inc.Recruiting
-
University of PittsburghTerminatedPelvic Organ Prolapse | Urinary RetentionUnited States
-
White River Junction Veterans Affairs Medical CenterMedical University of South Carolina; National Cancer Institute (NCI); University...RecruitingNon-muscle-invasive Bladder CancerUnited States
-
Clinique Beau SoleilCepheid; Team Languedoc Mutualité / Nouvelles technologiesCompletedNon-Invasive Bladder Urothelial Carcinoma | Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade | Non-Invasive Bladder Papillary Urothelial Carcinoma, High GradeFrance
-
Jørgen Bjerggaard JensenLaborie Medical Technologies Inc.; Cepheid; Vingmed Danmark A/S; OneMed A/SEnrolling by invitationUrinary Bladder NeoplasmsDenmark, Greenland
-
Nucleix Ltd.CompletedBladder CancerUnited States, Canada
-
National Taiwan University HospitalCompletedUrinary Bladder, Overactive
-
Institut Claudius RegaudCepheidUnknownNon Muscle Invasive Bladder Cancer | Treatment by BCGFrance